サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1296882

アレルギー免疫療法の世界市場2023-2030

Global Allergy Immunotherapy Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 160 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
アレルギー免疫療法の世界市場2023-2030
出版日: 2023年05月25日
発行: Orion Market Research
ページ情報: 英文 160 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のアレルギー免疫療法市場は、予測期間中にCAGR 8.2％で成長すると予測されています。患者のアレルギーに対する意識の高まりなどの要因が、アレルギー免疫療法産業の成長を促進すると予測されています。世界アレルギー機構によると、アレルギーの蔓延が増加しており、世界人口の約30％がアレルギー性鼻炎を患っています。米国疾病予防管理センター（CDC）によると、米国では成人の8％以上が副鼻腔炎と花粉症に苦しんでいます。このような組織による啓発により、各国政府は効果的な治療法としてアレルギー免疫療法の研究開発に予算を計上しています。したがって、この要因は予測期間中のアレルギー免疫療法市場の成長にプラスの影響を与えます。

消化器疾患の有病率の増加、ライフサイエンス研究分野への投資や資金調達の増加といった要因も、予測期間中のアレルギー免疫療法市場の成長を後押しします。アレルギー免疫療法は、低感作療法としても知られています。これは、様々な種類のアレルギーに取り組むことができる医療治療の一種です。世界中で様々な種類のアレルギーが著しく増加しています。薬物療法は、これらのアレルギー疾患の発生に取り組み、コントロールするには十分ではありません。そのため、アレルギー免疫療法市場開拓の大きな原動力となっています。これらの治療法の使用により、アレルギー物質に対する耐性レベルを構築し、障害の経過を変えることが可能になります。

セグメント別展望

アレルギー性鼻炎が最大セグメント

市場はタイプ別に、アレルギー性鼻炎、アレルギー性喘息、食物アレルギー、薬物アレルギー、その他に区分されます。アレルギー免疫療法市場では、アレルギー性鼻炎分野が最大の市場シェアを占めると予想されます。CDCセンターによると、米国では全人口の約8％がアレルギー性鼻炎に苦しんでいます。したがって、大人と子供の間で有病率が上昇していることが、このセグメントの成長を促進すると予想されます。

地域別展望

北米地域がアレルギー免疫療法の世界市場で大きなシェアを占めると予測

これらの地域の中で、アジア太平洋地域は予測期間中にアレルギー免疫療法市場で大きなシェアを占めると予測されています。同地域におけるアレルギー免疫療法市場の成長は、主に様々な種類のアレルギーに苦しむ患者数の増加、高血圧、喘息、アレルギー、糖尿病などの慢性疾患の有病率の増加といった要因がアレルギー免疫療法市場の成長を後押ししています。それとともに、アレルギー性喘息、湿疹、食物アレルギーの有病率の増加、ヘルスケア施設の改善、研究開発資金の増加、新製品や治療法の開拓も、この地域の市場シェアに貢献しています。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • 主要戦略分析

第4章 市場セグメンテーション

  • アレルギー免疫療法の世界市場：タイプ別
    • アレルギー性鼻炎
    • アレルギー性喘息
    • 食物アレルギー
    • 薬物アレルギー
    • その他
  • アレルギー免疫療法の世界市場：療法別
    • 皮下免疫療法
    • 舌下免疫療法
  • アレルギー免疫療法の世界市場：流通チャネル別
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Aimmune Therapeutics, Inc.
  • ALK-Abello A/S
  • Allergopharma（A Division of Merck KGaA）
  • Allergy Therapeutics PLC
  • Biomay AG
  • CircassiaPharmaceuticals PLC
  • DBV Technologies S.A.
  • Desentum Oy
  • HAL Allergy Group
  • Jubilant Life Sciences, Ltd.
  • LetiPharma
  • Merck KGaA
  • Sandoz, Inc.
  • Stallergenes GREER, Ltd.
  • Torii Pharmaceutical Co, Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL IMMUNOTHERAPY FOR ALLERGIC RHINITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL IMMUNOTHERAPY FOR ALLERGIC ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL IMMUNOTHERAPY FOR FOOD ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL IMMUNOTHERAPY FOR DRUG ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL IMMUNOTHERAPY FOR OTHERS ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 8. GLOBAL SUBCUTANEOUS ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SUBLINGUAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 11. GLOBAL ALLERGY IMMUNOTHERAPY FOR HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL ALLERGY IMMUNOTHERAPY FOR RETAIL PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL ALLERGY IMMUNOTHERAPY FOR ONLINE PHARMACY ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 18. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 20. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 21. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY TREATMENT, 2022 VS 2030 (%)
  • 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL IMMUNOTHERAPY FOR ALLERGIC RHINITIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL IMMUNOTHERAPY FOR ALLERGIC ASTHMA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL IMMUNOTHERAPY FOR FOOD ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL IMMUNOTHERAPY FOR DRUG ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL IMMUNOTHERAPY FOR OTHERS ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL SUBCUTANEOUS ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL SUBLINGUAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL ALLERGY IMMUNOTHERAPY FOR HOSPITAL PHARMACY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL ALLERGY IMMUNOTHERAPY FOR RETAIL PHARMACY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL ALLERGY IMMUNOTHERAPY FOR ONLINE PHARMACY ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. US ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. UK ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. ROE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027333

Global allergy immunotherapy market is anticipated to grow at a CAGR of 8.2% during the forecast period. Factor such as increasing awareness of allergies in patients is anticipated to propel the growth of the allergy immunotherapy industry. According to the World Allergy Organization, an increase in the pervasiveness of allergies has been witnessed and around 30% of the world population has allergic rhinitis. As per the Centers for Disease Control and Prevention (CDC), more than 8% of adults in the US suffer from sinusitis and hay fever. With the awareness created by these organizations; governments of different countries have sanctioned budgets for the R&D of allergy immunotherapy as an effective cure. Thus, this factor has a positive impact on the growth of the allergy immunotherapy market during the forecast period.

The factors such as the growing prevalence of gastrointestinal diseases, rising investments, and funding in the field of life science research boost the growth of the allergy immunotherapy market during the forecast period. Allergy immunotherapy is also known as hypo-sensitization. It is a type of medical treatment that allows for tackling various types of allergies. There has been significant growth in the various types of allergies across the globe. Pharmacotherapy is not enough to tackle and control the occurrence of these allergic disorders. Therefore, it is a major driving factor for the development of the allergy immunotherapy market. The use of these treatments enables building up the tolerance level against the allergic substances and enables altering the course of the disorders.

Segmental Outlook

The global allergy immunotherapy market is segmented based on treatment, type, and distribution channel. Based on type, the market is segmented into allergic rhinitis, allergic asthma, food allergy, drug allergy, and others. The asthma segment is expected to hold a significant market share due to the growing prevalence of asthma across the globe. Based on treatment, the market is bifurcated into subcutaneous immunotherapy and sublingual immunotherapy. The subcutaneous immunotherapy segment is expected to hold a considerable growth rate during the forecast period due to its effectiveness in treating several allergies such as asthma. Moreover, it is treatment options that have to alter one's immune system to cure the development of other allergies. Based on the distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Allergic Rhinitis will be the largest segment

Based on type, the market is segmented into allergic rhinitis, allergic asthma, food allergy, drug allergy, and others. The allergic rhinitis segment is expected to hold the largest market share in the allergy immunotherapy market. As per the Center for CDC around 8% of the total population is suffering from allergic rhinitis in the US. Therefore, the rising prevalence among adults and children is expected to propel the growth of the segment.

Regional Outlooks

The global Allergy Immunotherapy market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Europe market is anticipated to cater to a prominent growth over the forecast period. However, the Asia-Pacific region is projected to experience considerable growth in the Allergy Immunotherapy market.

The North American Region is anticipated to Hold a Significant Share in the Global Allergy Immunotherapy Market

Among these regions, the Asia-Pacific region is anticipated to account for a significant share of the Allergy Immunotherapy market during the forecast period. The growth of the allergy immunotherapy market in the region is primarily driven by factors such as the growing number of patients suffering from various types of allergies, and the growing prevalence of chronic diseases such as hypertension, asthma, allergies, and diabetes that fuel the growth of the allergy immunotherapy market. Along with it, the growing prevalence of allergic asthma, eczema, and food allergy improved healthcare facilities, growing funds from R&D, and the development of new products and therapy is also contributed to the market share in the region.

Market Players Outlook

The key players of the allergy immunotherapy market include Biomay AG, Aimmune Therapeutics, Inc., HAL Allergy Group, Allergopharma, Merck KGaA, Stallergenes Greer, Jubilant Life Sciences, Ltd., ALK-Abello A/S, Leti Pharma, and DBV Technologies. These market players are continuously adopting various strategies to expand their market share. For instance, in November 2018, Aimmune Therapeutics, Inc announced the closing of the $98 million equity investment by Nestle Health Science. The funding was provided to develop treatments for potentially life-threatening food allergies. Further, in October 2017, DBV Technologies entered into an R&D agreement for the treatment of birch allergies with standergness SA.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Market Players
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Allergy Immunotherapy Market by Type
    • 4.1.1. Allergic Rhinitis
    • 4.1.2. Allergic Asthma
    • 4.1.3. Food Allergy
    • 4.1.4. Drug Allergy
    • 4.1.5. Others
  • 4.2. Global Allergy Immunotherapy Market by Treatment
    • 4.2.1. Subcutaneous Immunotherapy
    • 4.2.2. Sublingual Immunotherapy
  • 4.3. Global Allergy Immunotherapy Market by Distribution Channel
    • 4.3.1. Hospital Pharmacy
    • 4.3.2. Retail Pharmacy
    • 4.3.3. Online Pharmacy

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Aimmune Therapeutics, Inc.
  • 6.2. ALK-Abello A/S
  • 6.3. Allergopharma (A Division of Merck KGaA)
  • 6.4. Allergy Therapeutics PLC
  • 6.5. Biomay AG
  • 6.6. CircassiaPharmaceuticals PLC
  • 6.7. DBV Technologies S.A.
  • 6.8. Desentum Oy
  • 6.9. HAL Allergy Group
  • 6.10. Jubilant Life Sciences, Ltd.
  • 6.11. LetiPharma
  • 6.12. Merck KGaA
  • 6.13. Sandoz, Inc.
  • 6.14. Stallergenes GREER, Ltd.
  • 6.15. Torii Pharmaceutical Co, Ltd.